HIV Medicine Shortages Followed Global Funding Cuts
Over half of surveyed global health groups faced supply gaps for essential HIV care throughout the past year.
Updated on Oct. 7, 2026 in Sexual Health
Live Poll
Should the U.S. government continue funding international HIV care and prevention programs?
More than half of the International Planned Parenthood Foundation member organizations reported running out of HIV tests, condoms, and pre-exposure prophylaxis over the past year. This report follows a significant reduction in international HIV care funding that occurred between 2024 and 2025.
Why it matters
The $2.1 billion drop in funding has directly impacted the availability of essential prevention and treatment tools in low- and middle-income countries. These shortages complicate ongoing efforts to maintain consistent access to care for vulnerable populations.
A survey of 40 member associations globally identified critical gaps in HIV tests, condoms, and pre-exposure prophylaxis. These findings emerge against a backdrop of a 25 percent reduction in government funding for HIV care in low- and middle-income nations.
The players
International Planned Parenthood Foundation
An international non-governmental organization that provides reproductive health services and HIV care.
Donald Trump
The current President of the United States who oversaw the scaling back of international HIV care funding.
UNAIDS
A joint United Nations program that coordinates the global response to HIV and AIDS.
KFF
A non-profit organization focused on national health issues and the analysis of international health policy.
The details
The shortages were triggered by a $2.1 billion decline in international HIV care funding during the second term of President Donald Trump. In response, the International Planned Parenthood Foundation allocated $600,000 in emergency funding to address supply gaps in priority countries, including Barbados, Lebanon, Madagascar, and São Tomé & Príncipe. Experts estimate that total supply gaps will exceed $1.5 million USD over the next two years as global supply chains face further pressure.
Timeline
Government funding for HIV care fell by $2.1 billion between 2024 and 2025.
Member organizations reported experiencing medicine shortages throughout the past year.
The International Planned Parenthood Foundation released its survey report in October 2026.
Projected supply gaps for essential HIV products are expected to reach $1.5 million over the next two years.
Health Landscape
This decline in financial support represents a stark departure from the long-standing international commitment represented by the President's Emergency Plan for AIDS Relief (PEPFAR). The resulting resource scarcity threatens to reverse decades of progress in managing HIV and preventing transmission.
If you rely on specific HIV prevention or treatment resources, it is worth discussing potential supply vulnerabilities with your healthcare provider to ensure your prescription remains secure. Staying informed about your local clinic's inventory can help you maintain consistent access to your medications.
The takeaway
Maintaining steady access to HIV medication is critical during periods of funding uncertainty. Readers should proactively confirm medication supply with their local clinic and ensure their care plan includes a strategy for potential supply disruptions.
Further reading
For more on the current status of global prevention efforts, explore our resources on Sexual Health.
Live Poll
Should the U.S. government continue funding international HIV care and prevention programs?
